As of September 2024, Sprint Bioscience AB has a market cap of $8.98M. This makes Sprint Bioscience AB the world's 33107th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $6.27M | -46.97% |
2023 | $11.82M | 213.74% |
2022 | $3.77M | -88.47% |
2021 | $32.67M | -37.57% |
2020 | $52.33M | -37.05% |
2019 | $83.12M | -41.06% |
2018 | $141.04M | -9.21% |
2017 | $155.34M | -26.92% |
2016 | $212.58M | -26.59% |
2015 | $289.57M | 215.99% |
2014 | $91.64M | - |